First Time Loading...

Annovis Bio Inc
NYSE:ANVS

Watchlist Manager
Annovis Bio Inc Logo
Annovis Bio Inc
NYSE:ANVS
Watchlist
Price: 9.98 USD 1.32%
Updated: Apr 19, 2024

Intrinsic Value

ANVS's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. [ Read More ]

The intrinsic value of one ANVS stock under the Base Case scenario is 5.5 USD. Compared to the current market price of 9.98 USD, Annovis Bio Inc is Overvalued by 45%.

Key Points:
ANVS Intrinsic Value
Base Case
5.5 USD
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Annovis Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ANVS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Annovis Bio Inc

Provide an overview of the primary business activities
of Annovis Bio Inc.

What unique competitive advantages
does Annovis Bio Inc hold over its rivals?

What risks and challenges
does Annovis Bio Inc face in the near future?

Has there been any significant insider trading activity
in Annovis Bio Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Annovis Bio Inc.

Provide P/S
for Annovis Bio Inc.

Provide P/E
for Annovis Bio Inc.

Provide P/OCF
for Annovis Bio Inc.

Provide P/FCFE
for Annovis Bio Inc.

Provide P/B
for Annovis Bio Inc.

Provide EV/S
for Annovis Bio Inc.

Provide EV/GP
for Annovis Bio Inc.

Provide EV/EBITDA
for Annovis Bio Inc.

Provide EV/EBIT
for Annovis Bio Inc.

Provide EV/OCF
for Annovis Bio Inc.

Provide EV/FCFF
for Annovis Bio Inc.

Provide EV/IC
for Annovis Bio Inc.

Show me price targets
for Annovis Bio Inc made by professional analysts.

What are the Revenue projections
for Annovis Bio Inc?

How accurate were the past Revenue estimates
for Annovis Bio Inc?

What are the Net Income projections
for Annovis Bio Inc?

How accurate were the past Net Income estimates
for Annovis Bio Inc?

What are the EPS projections
for Annovis Bio Inc?

How accurate were the past EPS estimates
for Annovis Bio Inc?

What are the EBIT projections
for Annovis Bio Inc?

How accurate were the past EBIT estimates
for Annovis Bio Inc?

Compare the revenue forecasts
for Annovis Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Annovis Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Annovis Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Annovis Bio Inc compared to its peers.

Compare the P/E ratios
of Annovis Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Annovis Bio Inc with its peers.

Analyze the financial leverage
of Annovis Bio Inc compared to its main competitors.

Show all profitability ratios
for Annovis Bio Inc.

Provide ROE
for Annovis Bio Inc.

Provide ROA
for Annovis Bio Inc.

Provide ROIC
for Annovis Bio Inc.

Provide ROCE
for Annovis Bio Inc.

Provide Gross Margin
for Annovis Bio Inc.

Provide Operating Margin
for Annovis Bio Inc.

Provide Net Margin
for Annovis Bio Inc.

Provide FCF Margin
for Annovis Bio Inc.

Show all solvency ratios
for Annovis Bio Inc.

Provide D/E Ratio
for Annovis Bio Inc.

Provide D/A Ratio
for Annovis Bio Inc.

Provide Interest Coverage Ratio
for Annovis Bio Inc.

Provide Altman Z-Score Ratio
for Annovis Bio Inc.

Provide Quick Ratio
for Annovis Bio Inc.

Provide Current Ratio
for Annovis Bio Inc.

Provide Cash Ratio
for Annovis Bio Inc.

What is the historical Revenue growth
over the last 5 years for Annovis Bio Inc?

What is the historical Net Income growth
over the last 5 years for Annovis Bio Inc?

What is the current Free Cash Flow
of Annovis Bio Inc?

Financials

Balance Sheet Decomposition
Annovis Bio Inc

Current Assets 10.2m
Cash & Short-Term Investments 5.8m
Other Current Assets 4.5m
Current Liabilities 4.3m
Accounts Payable 1.3m
Accrued Liabilities 3m
Non-Current Liabilities 13.7m
Other Non-Current Liabilities 13.7m
Efficiency

Earnings Waterfall
Annovis Bio Inc

Revenue
0 USD
Operating Expenses
-45m USD
Operating Income
-45m USD
Other Expenses
-11.2m USD
Net Income
-56.2m USD

Free Cash Flow Analysis
Annovis Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ANVS Profitability Score
Profitability Due Diligence

Annovis Bio Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
37/100
Profitability
Score

Annovis Bio Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

ANVS Solvency Score
Solvency Due Diligence

Annovis Bio Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Annovis Bio Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANVS Price Targets Summary
Annovis Bio Inc

Wall Street analysts forecast ANVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANVS is 36.11 USD with a low forecast of 13.13 USD and a high forecast of 75.6 USD.

Lowest
Price Target
13.13 USD
32% Upside
Average
Price Target
36.11 USD
262% Upside
Highest
Price Target
75.6 USD
658% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ANVS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ANVS Price
Annovis Bio Inc

1M 1M
+12%
6M 6M
+8%
1Y 1Y
-33%
3Y 3Y
-55%
5Y 5Y
+4%
10Y 10Y
+4%
Annual Price Range
9.98
52w Low
5.55
52w High
19.62
Price Metrics
Average Annual Return 31.12%
Standard Deviation of Annual Returns 97.12%
Max Drawdown -95%
Shares Statistics
Market Capitalization 105m USD
Shares Outstanding 11 010 000
Percentage of Shares Shorted 18.02%

ANVS Return Decomposition
Main factors of price return

What is price return decomposition?

ANVS News

Other Videos

Last Important Events
Annovis Bio Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Annovis Bio Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Annovis Bio Inc Logo
Annovis Bio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

105m USD

Dividend Yield

0%

Description

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The company is headquartered in Berwyn, Pennsylvania and currently employs 3 full-time employees. The company went IPO on 2020-01-29. The firm is engaged in developing treatments for neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s disease in Down syndrome (AD-DS). The firm's lead compound, ANVS401, is an orally administered drug being developed for chronic indications such as AD, PD and AD-DS. The firm's ANVS405 compound is being developed for acute indications, focused on protecting the brain after Traumatic brain injury (TBI) and/or stroke. ANVS405 is the same compound as ANVS401, but it is given intravenously in cases of acute head and brain trauma. The firm is also developing its compound, ANVS301 to increase cognitive capability in later stages of AD and dementia.

Contact

PENNSYLVANIA
Berwyn
1055 Westlakes Dr Ste 300
+16107273913.0
https://www.annovisbio.com/

IPO

2020-01-29

Employees

3

Officers

Founder, CEO, President & Executive Director
Dr. Maria L. Maccecchini Ph.D.
Chief Financial Officer
Mr. Henry Hagopian III, M.B.A.
Senior Vice President of Research & Development
Dr. Cheng Fang Ph.D.
Senior Vice President of Regulatory Operations
Ms. Eve M. Damiano M.S., RAC
Senior Vice President of Clinical Operations
Ms. Melissa Gaines

See Also

Discover More
What is the Intrinsic Value of one ANVS stock?

The intrinsic value of one ANVS stock under the Base Case scenario is 5.5 USD.

Is ANVS stock undervalued or overvalued?

Compared to the current market price of 9.98 USD, Annovis Bio Inc is Overvalued by 45%.